title: Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen.
abstract: Serology is used to predict vaccine induced protection against challenge with a heterologous strain of the same serotype of foot-and-mouth disease virus (FMDV). To evaluate the accuracy of such predictions, we compared the protection afforded to cattle vaccinated with the O(1) Manisa strain of FMDV against challenge with either a homologous (O(1) Manisa) or a heterologous strain (O(1) Campos). Serology by virus neutralization test (VNT) using O(1) Manisa antiserum predicted an acceptable protection against such a challenge. Two experiments were carried out to compare the results for consistency. A total of 78 naïve cattle were vaccinated with different antigen payloads (60-0.94 μg) of O(1) Manisa. They were challenged by intradermolingual inoculation with live FMDV, either O(1) Manisa or O(1) Campos. Unvaccinated naïve control cattle (n=20) were also challenged with either the O(1) Manisa or O(1) Campos viruses and all developed generalized FMD. The protection results for the vaccinated cattle revealed that higher payloads of O(1) Manisa vaccine were needed to protect against heterologous challenge compared to that for homologous challenge. The 50% protective dose (PD(50)) values for the vaccine in experiments 1 and 2 were found to be 28.78 and 9.44 for the homologous challenge and 3.98 and 5.01 for heterologous challenge. Furthermore, protection against O(1) Campos required a higher level of vaccine-induced antibody against this virus compared to the level of O(1) Manisa neutralizing antibody associated with protection against homologous challenge. The 50% protective level of in vitro neutralizing antibody was found to be log(10)1.827 for O(1) Campos and log(10)0.954 for O(1) Manisa based on O(1) Manisa based virus neutralization test.
authors.affiliation: Foot-and-Mouth Disease Virus Laboratory, Research and Development Centre, Indian Immunologicals Limited, Rakshapuram, Gachibowli Post, Hyderabad 500032, India.
authors.forename: Singanallur Balasubramanian
authors.initials: SB
authors.lastname: Nagendrakumar
authors.forename: Villuppanoor Alwar
authors.initials: VA
authors.lastname: Srinivasan
authors.forename: Muthukrishnan
authors.initials: M
authors.lastname: Madhanmohan
authors.forename: Shanmugam
authors.initials: S
authors.lastname: Yuvaraj
authors.forename: Satya
authors.initials: S
authors.lastname: Parida
authors.forename: Antonello
authors.initials: A
authors.lastname: Di Nardo
authors.forename: Jacquelyn
authors.initials: J
authors.lastname: Horsington
authors.forename: David James
authors.initials: DJ
authors.lastname: Paton
mesh_terms: D000818:Animals; D057134:Antibodies, Neutralizing / Q000097:blood; D000956:Antigens, Viral / Q000276:immunology*; D002417:Cattle; D002418:Cattle Diseases / Q000276:immunology / Q000517:prevention & control*; D056738:Cross Protection; D005536:Foot-and-Mouth Disease / Q000276:immunology / Q000517:prevention & control*; D029544:Foot-and-Mouth Disease Virus / Q000276:immunology*; D009500:Neutralization Tests; D014765:Viral Vaccines / Q000276:immunology*
chemical_list: D057134:Antibodies, Neutralizing; D000956:Antigens, Viral; D014765:Viral Vaccines